verified SJR 0,844 · Q1 • database Scopus / SJR & Web of Science indexed

United States · Springer

workspace_premium Q1 — Genetics lock_open Open Access

Journal of Cardiovascular Translational Research

Journal of Cardiovascular Translational Research is a journal indexed in SJR in Genetics and Molecular Medicine with an H index of 64. It has a price of 3190 €. It has an SJR impact factor of 0,844 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,844.

ISSN: 1937-5387

Publisher: Springer

Category: Genetics

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,844 Q1

H-index 64

Acceptance rate pie_chart

30% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

3.190 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,844

H-index

Docs (year)

165

Docs 3y

387

Total refs

8397

Cites 3y

1097

Citable 3y

367

Cites/Doc 2y

2.54

Ref/Doc

50.89

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bone Marrow Stem Cells for the Treatment of Ischemic Heart Disease: A Clinical Trial Review

William Campbell Little, M.D. In Memoriam

Determinants of Delayed Preconditioning Against Myocardial Stunning in Chronically Instrumented Pigs

Comparison of Efficacy and Cost of Iodine Impregnated Drape vs. Standard Drape in Cardiac Surgery: Study in 5100 Patients

Circulating Very Small Embryonic-Like Stem Cells in Cardiovascular Disease

Circulating MicroRNAs: a Potential Biomarker for Cardiac Damage, Inflammatory Response, and Left Ventricular Function Recovery in Pediatric Viral Myocarditis

Circulating Extracellular Vesicles Contain miRNAs and are Released as Early Biomarkers for Cardiac Injury

CircMACF1 Attenuates Acute Myocardial Infarction Through miR-500b-5p-EMP1 Axis

Chronic Treatment with Clenbuterol Modulates Endothelial Progenitor Cells and Circulating Factors in a Murine Model of Cardiomyopathy

Cellular Mechanisms in Mitral Valve Disease

Cardiovascular Medicine at the University of Minnesota: Lost and then Found in Translation

Cardiac Transcription Factors Driven Lineage-Specification of Adult Stem Cells

SHOW MORE ARTICLES

Building a Program in Translational Genomics

17beta-Estradiol Prevents Early-Stage Atherosclerosis in Estrogen Receptor-Alpha Deficient Female Mice

Bone Marrow Cell Therapy After Acute Myocardial Infarction. Back to Bench, or Ready for an Outcome Trial

Bone Marrow Cell Injection for Chronic Myocardial Ischemia: The Past and the Future

Biomaterials to Prevascularize Engineered Tissues

Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries

Association of Depression with Subclinical Coronary Atherosclerosis: a Systematic Review

Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy

Adult Stem Cells: From New Cell Sources to Changes in Methodology

Adult Human Adipose Tissue Contains Several Types of Multipotent Cells

Adipose-derived Stem Cells for Myocardial Infarction

FAQs

Journal of Cardiovascular Translational Research has an SJR of 0,844 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is 3190 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Journal of Cardiovascular Translational Research is 30%.

Journal of Cardiovascular Translational Research

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Journal of Cardiovascular Translational Research?

What is the APC / publication cost?

What is the acceptance rate?